| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |